(Q77333856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Animal models for studying the action of topoisomerase I targeted drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

J Thompson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

C F Stewart

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P J Houghton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

301-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

DNA topoisomerases: essential enzymes and lethal targets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

DNA topoisomerase-targeting antitumor drugs can be studied in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Comparative activity of oral and parenteral topotecan in murine tumor models: efficacy of oral topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Effects of CPT-11 (a unique DNA topoisomerase I inhibitor) on a highly malignant xeno-transplanted neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Efficacy of oral irinotecan against neuroblastoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Protocols for the treatment of human tumor xenografts with camptothecins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Schedule-dependent efficacy of camptothecins in models of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Eicosanoid-mediated Cl- secretion induced by the antitumor drug, irinotecan (CPT-11), in the rat colon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

The structural basis of camptothecin interactions with human serum albumin: impact on drug stability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

The important role of albumin in determining the relative human blood stabilities of the camptothecin anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Pharmacokinetics of camptothecins administered orally

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900143-2

7 January 2021

10.1016/S0167-4781(98)00143-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748639%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference